Form 4: HealthEquity Director Stuart Parker Receives Restricted Stock Unit Grant

HealthEquity, Inc. Director Stuart B. Parker was granted 2,003 restricted stock units, increasing his total beneficial ownership to 21,835 common shares.

Summary

• Stuart B. Parker, a Director of HealthEquity, Inc. (HQY), acquired 2,003 shares of common stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this acquisition was June 26, 2025.
• The acquisition price for these RSUs was $0 per share, indicating a grant rather than a purchase.
• Following this transaction, Stuart B. Parker's total beneficial ownership of HealthEquity common stock stands at 21,835 shares.
• Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
• The restricted stock units are set to vest in full on the date of HealthEquity's next annual stockholder meeting.
• Vested shares will be delivered to Mr. Parker on February 1, 2028, or earlier upon a change of control of the issuer, his termination of service, or his death, as defined in the issuer's 2024 equity incentive plan.

Sentiment

Score: 6

Explanation: The grant of RSUs to a director is a positive sign of alignment between management and shareholders, indicating continued commitment. It's a routine compensation event, not indicative of major strategic shifts, hence a moderately positive score.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The transaction is part of a structured equity incentive plan, indicating a standard approach to executive and director compensation.

Risks

• The value of the granted Restricted Stock Units is contingent on the future stock price of HealthEquity, Inc.
• The shares are subject to vesting conditions, meaning they are not immediately owned and could be forfeited if vesting conditions are not met (e.g., termination of service before vesting).

Future Outlook

The Restricted Stock Units granted to Director Stuart B. Parker are scheduled to vest in full on the date of HealthEquity's next annual stockholder meeting. The delivery of these vested shares is set for February 1, 2028, or earlier upon specific events such as a change of control, termination of service, or death, as outlined in the company's 2024 equity incentive plan.

Industry Context

This Form 4 filing details a routine equity compensation grant to a director, which is a common practice across various industries to incentivize and retain key personnel by aligning their financial interests with long-term company performance. Such grants are standard components of executive and director compensation packages in publicly traded companies, particularly in the healthcare technology and financial services sectors where HealthEquity operates.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) at a $0 price is a standard method of equity compensation for directors and executives across industries, including healthcare and financial technology, similar to practices at companies like Optum, Fidelity, or Vanguard, which also utilize equity incentives to align leadership with shareholder interests.
• The vesting schedule tied to the next annual stockholder meeting and a future delivery date (February 1, 2028) is a common structure for long-term incentive plans, comparable to those seen at peer companies aiming to foster long-term commitment and performance.

Corporate Governance

Related Party Transactions

• The acquisition of 2,003 Restricted Stock Units by Stuart B. Parker, a Director of HealthEquity, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with shareholders, potentially encouraging decisions that enhance long-term stock value. It also represents a form of dilution, though typically minor for individual grants.
• Employees: While not directly impacting all employees, such grants are part of a broader compensation philosophy that can influence overall company culture and talent retention strategies.

Next Steps

• The Restricted Stock Units will vest on the date of the issuer's next annual stockholder meeting.
• Vested shares are scheduled for delivery to Stuart B. Parker on February 1, 2028, or upon specific triggering events.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership, Executive Compensation